Entrada Therapeutics (TRDA)
(Delayed Data from NSDQ)
$14.95 USD
+0.46 (3.17%)
Updated May 16, 2024 04:00 PM ET
After-Market: $15.24 +0.29 (1.94%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | 0.25 |
EPS Last Quarter | 0.68 |
Last EPS Surprise | 278.95% |
ABR | 1.40 |
Earnings ESP
|
40.13% |
---|---|
Current Year | -0.27 |
Next Year | -3.62 |
EPS (TTM) | 0.63 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 35.00M | 30.00M | 143.80M | 39.80M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 35.00M | 30.00M | 162.30M | 56.40M |
Low Estimate | 35.00M | 30.00M | 130.00M | 15.00M |
Year ago Sales | 18.17M | 43.74M | 129.01M | 143.80M |
Year over Year Growth Est. | 92.63% | -31.41% | 11.46% | -72.32% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.25 | -0.43 | -0.27 | -3.62 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.06 | -0.27 | -0.41 | -4.47 |
High Estimate | 0.77 | -0.19 | -0.14 | -2.73 |
Low Estimate | -0.06 | -0.84 | -0.41 | -4.47 |
Year ago EPS | -0.78 | 1.02 | -0.20 | -0.27 |
Year over Year Growth Est. | 132.05% | -142.16% | -35.00% | -1,238.29% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 1 | 2 | 0 |
Up Last 60 Days | 2 | 1 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 0 | 1 |
Down Last 60 Days | 0 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.25 | -0.43 | -0.27 | -3.62 |
7 Days Ago | 0.25 | -0.43 | -0.27 | -3.62 |
30 Days Ago | -0.33 | -0.44 | -1.54 | -2.78 |
60 Days Ago | -0.51 | -0.55 | -1.51 | -2.78 |
90 Days Ago | -0.47 | -0.52 | -1.40 | -2.73 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.36 | -0.56 | -0.34 | -4.06 |
Zacks Consensus Estimate | 0.25 | -0.43 | -0.27 | -3.62 |
Earnings ESP | 40.13% | -28.08% | -24.39% | -12.26% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.68 | -0.29 | 1.02 | -0.78 | NA |
Estimate | -0.38 | -0.07 | -0.55 | -0.43 | NA |
Difference | 1.06 | -0.22 | 1.57 | -0.35 | 0.52 |
Surprise | 278.95% | -314.29% | 285.45% | -81.40% | 42.18% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more